Supplementation ofn-3 polyunsaturated fatty acids In pulmonary disease;Suplementacja kwasów omega-3 w wybranych chorobach układu oddechowego

Polski Merkuriusz Lekarski

Volumn 32, Issue 187, 2012, Pages 55-58

  Omernik, Andrzej ^a  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF NATIONAL DEFENSE   (Poland)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Docosahexaenoic acid; Lung cancer; N 3 polyunsaturated fatty acids; Pneumonia

Indexed keywords

OMEGA 3 FATTY ACID;

ASTHMA; CHRONIC DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; HUMAN; LUNG DISEASE; REVIEW;

ASTHMA; CHRONIC DISEASE; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; LUNG DISEASES;

EID: 84856943419     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Aiperovich M., Neuman M.I., Willett W.C. et al.: Fatty acid intake and the risk of community-acquired pneumonia in US women. Nutrition., 2007; 23 (3); 196-202. (Pubitemid 46367565)
2. Bravo M.G., de Antuneo R.J., Toledo J. et al.: Effects of eicosapentaenoic and docosahexaenoic acid concentrate on a human lung carcinoma grown in nude mice. Lipids, 1991; 26 (11); 866-870.
3. Burr M.L, Fehily A.M., Gilbert J.F.: Effect of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet, 1989; 2; 757-761. (Pubitemid 19234807)
4. Eaton S.B., Konner M.: Paleolithic nutrition. A consideration of its nature and current implications. New Engl. J. Med., 1985; 312; 283-289. (Pubitemid 15199367)
5. European Food Safety Authority: Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J., 2010; 8 (3); 1461.
6. Hwang I., Cha A., Lee H. et al.: N-3 polyunsaturated fatty acids and atopy in Korean preschoolers. Lipids, 2007; 42 (4); 345-349. (Pubitemid 46668930)
7. Lifschitz C.: Kwas dokozaheksaenowy: "najcieżej pracujacy" kwas tłuszczowy z rodziny omega-3. Stand. Med. Ped., 2011; 8; 237-248.
8. Matsuyama W., Mitsuyama H., Watanabe M. et al.: Effects of Omega-3 Polyunsaturated Fatty Acids on Infammatory Markers in COPD. Chest, 2005; 128; 3817-3827.
9. Meij B.S., Langiu J.A., Smit E.F. et al.: Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J. Nutr., 2010; 140 (10); 1774-1780.
10. Merchant A.T., Gary C.C., Rimm E.B. et al.: Intake of n-6 and n-3 fatty acids and fish and risk of community acquired pneumonia in US men. Am. J. Clin. Nutr., 2005; 82; 668-674.
11. Murphy R.A., Mourtzaiks M., Chu Q.S. et al.: Supplementation with fish oil increase first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer, 2011; 15; 117 (16); 3774-3780.
12. Murphy R.A., Mourtzaiks M., Chu Q.S. etal.: Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J. Nutr., 2010; 140 (9); 1602-1606.
13. Pierre M., Husson M.O, Le Berre R. et al.: Omega-3 polyunsaturated fatty acids improved host response in chronic Psudomonas aeruginosa lung infection in mice. Am. J. Physiol. Lung Cell Mol. Physiol., 2007; 292 (6); 1422-1431.
14. Serini S., Trombino S., Olivia F. et al.: Docosahexaenoic acid induces apoptosis in lung cancer cells by incresaingMKP-1 and down-regulating P-ERK1/2 and p-p38 expression. Apoptosis, 2008; 13 (9); 1172-1183.
15. Simopoulos A.P.: Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr, 1999; 70 (supl.); 560S-569S. (Pubitemid 29407138)
16. Simopoulos A.P.: Symposium: Role of poultry products in enriching the human diet with N-3 PUFA. Human requirement for N-3 polyunsaturated fatty acids. Poultry Science, 2000; 79; 961-970.
17. Shahar E., .Boland L.L., Folsom A.R. et al.: Docosahexaenoic Acid and smoking-related Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med., 1999;159; 1780-1785. (Pubitemid 29275042)
18. Szajewska H.: Zasady suplementacji kwasów tłuszczowych omega-3. Med. Prakt. Ped., 2011; 4; 83-86.
19. Tecklenburg-Lund S., Mickleborough T.D., Turner L A et al.: Randomized controlleed trial of fish oil and montelukast and their combination on airway infalmationandhyperpnea- inducedbronchoconstriction. PioSONE, 5 (10); e13487.
20. Tiesset H., Bernard H., Bartke N. et al.: n-3 long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/-mice. J. Nutr., 2011;141 (6); 1101-1107.
21. Tiesset H., Pierre M., Desseyn J.L. et al.: Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J. Nutr., 139; 82-89.